California Public Employees Retirement System cut its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 3.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 431,886 shares of the industrial products company’s stock after selling 13,176 shares during the period. California Public Employees Retirement System’s holdings in Xylem were worth $51,610,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Orion Porfolio Solutions LLC boosted its stake in shares of Xylem by 1.0% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after acquiring an additional 74 shares in the last quarter. Quest Investment Management LLC raised its stake in shares of Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock valued at $1,119,000 after acquiring an additional 77 shares in the last quarter. SWS Partners lifted its holdings in Xylem by 1.1% in the 4th quarter. SWS Partners now owns 7,402 shares of the industrial products company’s stock worth $1,008,000 after purchasing an additional 82 shares during the last quarter. Notis McConarty Edward lifted its holdings in Xylem by 0.3% in the 4th quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock worth $4,314,000 after purchasing an additional 86 shares during the last quarter. Finally, Moneco Advisors LLC boosted its position in Xylem by 4.6% during the fourth quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock worth $279,000 after purchasing an additional 90 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.
Xylem Stock Performance
NYSE XYL opened at $120.82 on Tuesday. The company’s fifty day moving average is $113.40 and its two-hundred day moving average is $123.26. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The firm has a market capitalization of $28.72 billion, a price-to-earnings ratio of 30.05, a P/E/G ratio of 1.75 and a beta of 1.03.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.
Insider Buying and Selling
In other news, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.32% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently issued reports on XYL. CLSA raised shares of Xylem to a “hold” rating in a report on Thursday, June 25th. Citigroup cut their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Oppenheimer decreased their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. JPMorgan Chase & Co. lowered their price target on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Finally, Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $153.15.
Read Our Latest Research Report on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
